Does sodium valproate increase clinical effects of diazepam? Double blind study. 1989

O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
Inst. Organic Chemistry and Biochemistry, Czechoslovak Acad. Sci., Prague.

UI MeSH Term Description Entries
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
November 1987, Journal of neurology, neurosurgery, and psychiatry,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
July 1996, Indian pediatrics,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
January 2004, QJM : monthly journal of the Association of Physicians,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
April 1992, Cephalalgia : an international journal of headache,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
May 2022, International clinical psychopharmacology,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
October 2007, European journal of neurology,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
February 1987, Ugeskrift for laeger,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
June 1974, Current therapeutic research, clinical and experimental,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
October 1999, Journal of neurology, neurosurgery, and psychiatry,
O Vinar, and A Dvorák, and E Vinarová, and M Fácková, and N Pavlícek, and T Tosnerová, and G Husovská
April 2021, The journal of headache and pain,
Copied contents to your clipboard!